Renerve (ASX: RNV) said that a recent comparative study showed that patients undergoing peripheral nerve surgery who used its NervAlign nerve cuff saw a major decrease in post-surgery pain compared to patients who did not use the nerve cuff, according to a Friday Australian bourse filing.
Patients who were treated with the nerve cuff were more likely to indicate they would have their procedure again.
The nerve cuff is designed to protect repaired and regenerating nerves during the healing process after peripheral nerve injuries or repair surgery, per the filing.
Its shares surged over 31% on market close on Friday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。